G Surgiwear IPO Details

MAINBOARD

G Surgiwear IPO DRHP (Draft Red Herring Prospectus) has been Filed With SEBI.

The Lead Managers for G Surgiwear IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Motilal Oswal Investment Advisors Ltd., Nuvama Wealth Management Ltd.. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the G Surgiwear Limited DRHP.

G Surgiwear IPO Details

Open Date
-
Close Date
-
Listing Date
-
Issue Price
₹0 - ₹0
Face Value
₹10 per share
Lot Size
0
GMP
₹0
Issue Type
IPO
Listing On
NSE, BSE
Type
Book Built Issue
Share holding pre issue
5,41,26,560 shares
Share holding post issue
-
Total Issue Size
-
Fresh Issue
-
Offer for Sale
-
DRHP Status
Filed With SEBI

G Surgiwear IPO Lot Size

ApplicationLotsSharesAmount
To be announced

G Surgiwear IPO Reservation

Promoter Holding

Pre Issue:92.96%
Post Issue:-
Promoter Names:
Ghanshyam Das Agarwal, Renu Agarwal, Vinamra Agarwal, Rishu Agarwal, Ghanshyam Das Agarwal HUF

Documents

G Surgiwear IPO Valuations

ROE:30.30%
ROCE:29.66%
DEBT/EQUITY:0.49
RONW:30.30%
PAT MARGIN:25.77%

G Surgiwear Financial Information

Period Ended30 Jun 202531 Mar 202531 Mar 202431 Mar 2023
Assets349.10324.59270.88211.22
Total Income44.68224.85169.13151.24
Profit After Tax5.6157.9522.5013.54
EBITDA14.2998.9854.7240.03
NET Worth197.43191.25133.13110.92
Reserves and Surplus196.11189.93131.81109.60
Total Borrowing121.6293.55102.2672.98
Amount in ₹ Crore

About G Surgiwear IPO

Incorporated in 1990, the Company is engaged in the design, development, and manufacturing of surgical products and medical implantable devices, serving healthcare providers across domestic and international markets. Its diversified product portfolio includes disposable surgical drapes and dressings, hydrocephalus shunts, orthopaedic implants, bone grafting products, lumbar drainage systems, and cranial devices, catering to a wide range of surgical and therapeutic applications.

A significant portion of the Company’s offerings fall under Class C and Class D medical device categories, which are subject to stringent regulatory approvals and clinical evaluation requirements. The Company’s ability to manufacture and commercialize such products reflects its strong regulatory compliance, quality systems, and technical capabilities.

As of September 30, 2025, the Company offered 1,628 stock keeping units (SKUs) across multiple categories, including disposable drapes and dressings, cranial fixation systems, bone cement products, and other implantable and consumable medical devices.

The Company operates a DSIR-recognized in-house research and development centre located in Shahjahanpur, Uttar Pradesh, supporting continuous product innovation and development. It holds 31 Indian patents and 8 international patents, and has recently launched advanced products such as interference screws and hip prostheses, expanding its orthopaedic portfolio.

Manufacturing operations are carried out at an integrated facility in Shahjahanpur, equipped with advanced, partially in-house-developed machinery. The facility is certified under WHO-GMP and multiple ISO standards, enabling scalable production while maintaining stringent quality controls.

The Company has established a robust domestic distribution network comprising 36 super-stockists and 554 distributors across 23 states and union territories. Internationally, it exports products to over 40 countries through 58 distributors, with presence across Africa, South Asia, and South America.

Through its strong R&D capabilities, regulated product portfolio, integrated manufacturing infrastructure, and extensive distribution network, the Company is positioned as a diversified medical devices manufacturer addressing critical surgical and healthcare needs.

Strength Of G Surgiwear IPO

To be announced

Risk Of G Surgiwear IPO

To be announced

Objectives G Surgiwear IPO

1. Financing the capital expenditure requirements of the Company through purchase of machinery for our manufacturing facility located at Khasra No.: 771, 773, 776/1, 779/2, 777 and, 778, Village Hathaura Buzurg, Pargana and Tehsil Sadar, Shahjahanpur – 242001, Uttar Pradesh, India (“Manufacturing Facility”)

2. Pre-payment/ re-payment, in part or full, of certain outstanding borrowings availed by our Company; and

3. General corporate purposes

Company Contact Details

G. Surgiwear Ltd. Address

Village Rasoolpur Jehanganj,

Shahjahanpur, Uttar Pradesh, 242001

Phone: +91 75185 03415

Email: piyush.cs@surgiwear.net

WebSite: http://www.surgiwear.co.in/

Registrar Contact Details

Name: Bigshare Services Pvt Ltd
Phone: +91-22-62638200

G Surgiwear IPO - FAQs

The G Surgiwear IPO is a MAINBOARD public issue comprising 0 equity shares with a face value of ₹10 each, aggregating to a total issue size of . The issue price has been fixed at ₹0 per equity share, and the minimum application size is 0 shares.

The IPO opens for subscription on TBA, and closes on TBA.

Bigshare Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

The G Surgiwear IPO opens on TBA.

G Surgiwear IPO lot size is 0, and the minimum amount required for application is ₹0.

You may apply for the G Surgiwear IPO online by using either the UPI or ASBA payment method. The ASBA facility is available through the net banking platform of your respective bank. The UPI-based IPO application option is typically provided by brokers that do not offer banking services. For detailed guidance on the online IPO application process, please refer to the procedures outlined by Zerodha, Groww, Upstox, 5Paisa, Paytm Money, Fyers, Alice Blue, Nuvama, HDFC Bank, ICICI Direct, Kotak Securities, Axis Direct, and SBI Bank.

The Basis of Allotment for the G Surgiwear IPO is scheduled to be finalized on TBA. Subsequently, the shares allotted will be credited to investors’ demat accounts by TBA. Investors are advised to regularly check the G Surgiwear IPO allotment status for updates.

The listing date for the G Surgiwear IPO has not yet been officially announced. However, the tentative listing date is scheduled for TBA.

G Surgiwear IPO Grey Market Premium (GMP) refers to the unofficial price at which the company’s IPO shares are traded in the grey market prior to their listing on the stock exchange. The GMP serves as an indicator of investor demand, expected listing gains, and the overall market sentiment toward the IPO.

As of now, the current GMP stands at TBA.

Comments